MARKET RADAR
SENSEX     NIFTY      Refresh
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Natco Pharma
Natco Pharma
BSE: 524816|NSE: NATCOPHARM|ISIN: INE987B01018|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
May 28, 17:00
410.45
-5.7 (-1.37%)
VOLUME 39,749
LIVE
NSE
May 28, 17:00
410.70
-2.3 (-0.56%)
VOLUME 165,035
Business News on Natco Pharma
Select Year: 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2000-2004
Won license to make one of Bayers product: Natco's CFO 

3.59 pm | 12 Mar 2012 |  Source: CNBC-TV18

In an interview with CNBC-TV18, Bhaskar Narayana, finance director & CFO of Natco Pharma spoke about the judgment where the company is granted compul...

Natco wins compulsory license from Bayer for cancer drug 

3.12 pm | 12 Mar 2012 |  Source: Moneycontrol.com

In a landmark judgement by India's Patent Office, Natco Pharma has won a compulsory license from Bayer for patent protected anti-cancer drug Nexavar, ...

See good boost in revenues in FY13: Natco Pharma 

3.20 pm | 18 Jan 2012 |  Source: CNBC-TV18

In an interview to CNBC-TV18, Bhaskar Narayana, chief financial officer of Natco Pharma says, FY13 should see atleast one abbreviated new drug applica...

QIP funds will be used for capex: Natco Pharma 

11.35 am | 08 Dec 2011 |  Source: CNBC-TV18

In an intervies to CNBC-TV18, Bhaskar Narayana, finance director and chief financial officer of Natco Pharma spoke about the latest happenings in his ...

1
Quick Links for Natco Pharma
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.